Moses Makunje
CIK: 0002001938
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NUVB
Nuvation Bio Inc.
Officer
Discretionary Trading P&L
Holdings
About Makunje Moses
Makunje Moses (SEC CIK 0002001938) files insider reports with the SEC as Officer of Nuvation Bio Inc. (NUVB).
Signal8 holds 2 ownership filings by Makunje Moses, all Form 4s, filed between Mar 4, 2025 and Mar 3, 2026. Those filings report 2 transactions, from Feb 28, 2025 to Feb 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Makunje Moses's filings is in NEW YORK, NY.
Recent filings by Makunje Moses
Other insiders filing for Nuvation Bio Inc. (NUVB)
- Hattersley Gary, CHIEF SCIENTIFIC OFFICER
- Sauvage Philippe, Chief Financial Officer
- Markel Stacy, CHIEF PEOPLE OFFICER
- Wentworth Kerry, CHIEF REGULATORY OFFICER
- Mashal Robert, Director
- VERNON W ANTHONY, Director